Investigating the impact of drug markets and tourism on HIV and HCV rates
Ethno-epidemiology of HCV, HIV and Overdose associated with Drug Markets and Drug Tourism
This study looks at how drug availability and travel between San Diego and Tijuana impact the health risks, like HIV and overdose, for people who use injectable drugs, and it invites those affected to share their experiences to help understand these issues better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-10767813 on NIH RePORTER |
What this research studies
This research examines how drug markets and drug tourism between San Diego and Tijuana affect the rates of HIV, HCV, and overdose among people who inject drugs. By analyzing trends in drug availability and pricing, the study aims to understand how these factors influence risky behaviors that could lead to increased health risks. The research employs a combination of epidemiological data and ethnographic methods to gather insights from affected communities. Participants may provide valuable information about their experiences and behaviors related to drug use across the border.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who inject drugs and have experience with drug markets in both San Diego and Tijuana.
Not a fit: Patients who do not engage in drug use or have no connection to the drug markets in these regions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved public health strategies and interventions to reduce the incidence of HIV and HCV among at-risk populations.
How similar studies have performed: Previous research has shown that understanding the dynamics of drug markets can significantly inform public health responses, suggesting that this approach has potential for success.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Strathdee, Steffanie a. — University of California, San Diego
- Study coordinator: Strathdee, Steffanie a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.